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Abstract 
Over the last 50 years the prognosis for growth and pubertal development 
in children with type one diabetes mellitus has improved. Considerably, 
however growth failure can occur in diabetic children with long standing 
poor glyceamic control. 
The aim of this study is to assess physical growth and pubertal 
Development in a group of children with type 1 DM of diabetic children 
and to evaluate the effect of  duration of illness, and degree of glyceamic 
Control on growth and sexual maturation.  
Anthropometric measurement of height, weight, body mass index, 
pubertal status, as well as bone age were assessed in 138 children with 
Type1 DM aged, 1 – 17 years, treated in two diabetic centers, 
Thirty eight patients (27.5%) had stunted growth, defined as height for 
age < - 2 SD, fifteen of these patients were in age group 9 -17 years, 
growth failure was positively correlated with level of glycosylated 
hemoglobin (HbA1c) (P = 0.001), there was no gender predilection 
shown. 
Twenty four patients (14.4%) had moderate under weight defined as 
weight for age < -2SD, nine patients (6.5 %) had sever under weight, 
defined as weight for age <- 3SD. , under weight was positively 
correlated with level of glycosylated hemoglobin (P =0.002). 
 V
Thirty-two (23.2%) patients had delayed bone age, twenty nine of these 
patients were in age group 9 – 17years. 
Ten females (20%) and nine males (16.9%) of adolescents, shown 
delayed sexual maturation with positive correlation with poor glyceamic 
control. 
This study revealed  growth retardation and delayed skeletal and sexual 
maturation in young Sudanese patients with insulin dependent diabetes 
mellitus, and emphasized the importance of strict glyceamic control. 
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  ﺑﺴﻢ اﷲ اﻟﺮﺣﻤﻦ اﻟﺮﺣﻴﻢ
  ﻣﻠﺨﺺ اﻟﺪراﺳﺔ
ﻤﺎﹰ ﺍﻟﻤﺎﻀﻴﺔ ﺍﻻﻨﺫﺍﺭ ﻟﻠﻨﻤﻭ ﻭﺍﻟﺘﻁﻭﺭ ﺍﻟﺠﻨﺴﻲ ﻓﻲ ﺍﻻﻁﻔـﺎل ﺍﻟﻤـﺼﺎﺒﻴﻥ ﻥ ﻋﺎ ﻴﻋﻠﻲ ﻤﺭ ﺍﻟﺨﻤﺴ      
 ﻓﻲ ﻨﺴﺒﺔ ﺍﻟﻨﻤﻭ ﺍﻟﺠﺴﻤﻲ ﻭﺍﻟﺠﻨﺴﻲ ﻓـﻲ ﺘﺤﺴﻨﺎﹰ ﻤﻠﺤﻭﻅﺎﹰ  ﺤﺩﺙ ﺒﺩﺍﺀ ﺍﻟﺴﻜﺭﻱ ﻤﻌﺘﻤﺩ ﺍﻻﻨﺴﻭﻟﻴﻥ ﻗﺩ 
ﺃﻁﻔﺎل ﺩﺍﺀ ﺍﻟﺴﻜﺭ ﻤﻌﺘﻤﺩ ﺍﻻﻨﺴﻭﻟﻴﻥ ﺇﻻ ﺍﻥ ﻋﺩﻡ ﺘﻨﻅﻴﻡ ﺍﻟﺴﻜﺭ ﻨﻔﺴﻪ ﻗﺩ ﻴﺅﺩﻱ ﺇﻟﻰ ﺘﺄﺨﺭ ﻓﻲ ﺍﻟﻨﻤـﻭ 
ﻤﻥ ﺫﻟﻙ ﻓﺸل ﺍﻟﻨﻤﻭ ﻗﺩ ﻴﺤﺩﺙ ﻓﻲ ﻤﺭﻀﻲ ﺍﻟﺴﻜﺭﻱ ﺫﻭ ﺍﻟﺘﻨﻅـﻴﻡ ﻋﻠﻲ ﺍﻟﺭﻏﻡ ، ﺍﻟﺠﺴﻤﻲ ﻭﺍﻟﺠﻨﺴﻲ 
  .ﺍﻟﺴﻲﺀ ﻁﻭﻴل ﺍﻻﻤﺩ
ﺍﻟﻬﺩﻑ ﻤﻥ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻫﻭ ﺘﻘﻴﻴﻡ ﺍﻟﻨﻤﻭ ﺍﻟﺠﺴﻤﻲ ﻭﺍﻟﺠﻨﺴﻲ ﻓﻲ ﺍﻻﻁﻔﺎل ﻭﺍﻟﻴﺎﻓﻌﻴﻥ ﺍﻟﻤﺼﺎﺒﻴﻥ      
ﺒﺩﺍﺀ ﺍﻟﺴﻜﺭﻱ ﻤﻌﺘﻤﺩ ﺍﻻﻨﺴﻭﻟﻴﻥ ﻭﺘﻘﻴﻴﻡ ﺍﺭﺘﺒﺎﻁ ﻓﺘﺭﺓﺍﻟﻤﺭﺽ ﻭﺩﺭﺠﺔ ﺘﻨﻅﻴﻡ ﺍﻟﺴﻜﺭﻱ ﻭﺍﺜﺭﻫﺎ ﻋﻠـﻲ 
  .ﺝ ﺍﻟﺠﻨﺴﻲﺍﻟﻨﻤﻭ ﺍﻟﺠﺴﻤﻲ ﻭﺍﻟﻨﻀﻭ
ﺍﻟﺨﺼﺎﺌﺹ ﺍﻟﺠﻨﺴﻴﺔ ﻭﺍﻟﻨﻤﻭ ، ﻤﺅﺸﺭ ﻜﺘﻠﺔ ﺍﻟﺠﺴﻡ ، ﺍﻟﻭﺯﻥ، ﺍﻟﻤﻘﺎﻴﻴﺱ ﺍﻟﻤﻌﻴﺎﺭﻴﺔ ﻟﻠﻁﻭل ﺘﻡ ﺘﻘﻴﻴﻡ      
ﺍﻋﻤـﺎﺭﻫﻡ ﺒـﻴﻥ ﻋـﺎﻡ ، ﺍﻷﻨﺴﻭﻟﻴﻥ ﺒﺩﺍﺀ ﺍﻟﺴﻜﺭﻱ ﻤﻌﺘﻤﺩ ﺎﹰ ﻤﺼﺎﺒ ﺍﻟﻌﻅﻤﻲ ﻓﻲ ﻤﺎﺌﺔ ﻭﺜﻼﺜﻭﻥ ﻁﻔﻼﹰ 
  . ﻭﻫﺅﻻﺀ ﻴﺨﻀﻌﻭﻥ ﻟﻠﻌﻼﺝ ﻓﻲ ﻤﺭﻜﺯﻴﻥ ﻟﻌﻼﺝ ﺍﻟﺴﻜﺭﻱﺎﹰﻭﺴﺒﻌﺔ ﻋﺸﺭ ﻋﺎﻤ
ﻴﻌﺎﻨﻭﻥ ﻤﻥ ﻗﺼﺭ ﺍﻟﻁﻭل ﺍﻟﺫﻱ ﻴﻌﺭﻑ ﺒﻌﻼﻗﺔ ﺍﻟﻁﻭل ﻟﻠﻌﻤـﺭ %( 5.72)ﻴﺽ ﺜﻤﺎﻨﻴﺔ ﻭﺜﻼﺜﻭﻥ ﻤﺭ 
 ﻴﻤﺜﻠﻭﻥ ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﻌﻤﺭﻴﺔ ﻤـﻥ ﺒﻴﻨﻬﻡﺨﻤﺴﺔ ﻋﺸﺭ ﻤﻥ ،  ﻤﻌﻴﺎﺭﻱ ﺍﻨﺤﺭﺍﻑﺍﻗل ﻤﻥ ﺴﺎﻟﺏ ﺍﺜﻨﻴﻥ 
ﺩﻻﻟـﺔ )ﻭﻨﻘﺼﺎﻥ ﺍﻟﻁﻭل ﺍﺭﺘﺒﻁ ﺍﻴﺠﺎﺒﺎﹰ ﻤﻊ ﻫﻴﻤﻭﻗﻠﻭﺒﻴﻥ ﺍﻟـﺴﻜﺭ ، ﺍﻟﺘﺎﺴﻌﺔ ﺇﻟﻲ ﺍﻟﺴﺎﺒﻌﺔ ﻋﺸﺭ ﻋﺎﻤﺎﹰ 
  . ﺍﺭﺘﺒﺎﻁ ﺒﺎﺨﺘﻼﻑ ﺍﻟﺠﻨﺴﻴﻥﻜﻤﺎ ﻟﻡ ﻴﺘﺒﻴﻥ ﺃﻱ، (100.0= ﺍﺤﺼﺎﺌﻴﺔ 
ﻴﻌﺎﻨﻭﻥ ﻤﻥ ﻨﻘﺼﺎﻥ ﻤﺘﻭﺴﻁ ﺍﻟﻭﺯﻥ ﺍﻟﺫﻱ ﻴﻌﺭﻑ ﺒﻌﻼﻗﺔ %( 4.41)ﺍﺭﺒﻌﺔ ﻭﻋﺸﺭﻭﻥ ﻤﺭﻴﺽ     
 ﺨﻴﻡﻴﻌﺎﻨﻭﻥ ﻤﻥ ﻨﻘﺼﺎﻥ ﻭ %( 5.6)ﺘﺴﻌﺔ ﻤﺭﻀﻲ ، ﻤﻌﻴﺎﺭﻱﺍﻨﺤﺭﺍﻑ ﺍﻟﻭﺯﻥ ﺍﻗل ﻤﻥ ﺴﺎﻟﺏ ﺍﺜﻨﻴﻥ 
ﻨﻘـﺼﺎﻥ ، ﺍﻨﺤـﺭﺍﻑ ﻤﻌﻴـﺎﺭﻱ ﺍﻟﻭﺯﻥ ﺍﻟﺫﻱ ﻴﻌﺭﻑ ﺒﻌﻼﻗﺔ ﺍﻟﻭﺯﻥ ﻟﻠﻌﻤﺭ  ﺒﺎﺍﻗل ﻤﻥ ﺴﺎﻟﺏ ﺜﻼﺜﺔ 
    .(200.0= ﺩﻻﻟﺔ ﺍﺤﺼﺎﺌﻴﺔ )ﺭﺘﺒﻁ ﺍﻴﺠﺎﺒﻴﺎﹰ ﻤﻊ ﻤﺴﺘﻭﻱ ﺍﻟﻬﻴﻤﻭﻗﻠﻭﺒﻴﻥ ﺍﻟﺴﻜﺭﻱ ﻭﺯﻥ ﺍﺍﻟ
ﺘﺴﻌﺔ ﻭﻋﺸﺭﻭﻥ ﻤﻨﻬﻡ ﻓﻲ ﺍﻟﻤﺠﻤﻭﻋـﺔ . ﺃﺜﻨﻴﻥ ﻭﺜﻼﺜﻭﻥ ﻤﺭﻴﻀﺎﹰ ﻭﺠﺩ ﻟﺩﻴﻬﻡ ﺘﺎﺨﺭ ﺍﻟﻨﻤﻭﻱ ﺍﻟﻌﻅﻤﻲ 
  .ﺍﻟﻌﻤﺭﻴﺔ ﻤﻥ ﺘﺴﻌﺔ ﺇﻟﻲ ﺴﺒﻌﺔ ﻋﺸﺭ ﻋﺎﻤﺎﹰ
ﺍﻴﺠﺎﺒﻴﺎ ﻤـﻊ ﺴـﻭﺀ  ﻭﻗﺩ ﺍﺭﺘﺒﻁ ﺠﻨﺴﻲﻼﺤﻅ ﻟﺩﻴﻬﻡ ﺘﺄﺨﺭ ﺍﻟﻨﻤﻭ ﺍﻟ ﺘ ﺫﻜﻭﺭ ﺘﺴﻌﺔﻋﺸﺭﺓ ﺍﻨﺎﺙ ﻭ     
  .ﺘﻨﻅﻴﻡ ﺍﻟﺴﻜﺭﻱ
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Chapter one 
INTRODUCTION & LITERATURE 
REVIEW 
 
1.1.1 Definition:- 
Diabetes mellitus is, or syndrome of disturbed energy 
homestasis caused by deficiency of insulin or of its action resulting 
in abnormal metabolism of carbohydrate, protein, and fat. 
 It is the most common endocrine metabolic disorder of 
childhood and adolescence with important consequences on 
physical and emotional development(1).  
1.1.2 Historical background:- 
Diabetes mellitus has both ancient roots and expanding 
research base. 
Polyuric state was recognized by ancient Egyptians at 1550 
BC. The word diabetes comes from Greek word meaning siphon. It 
was described by the Greek physician, Aretaeus at the first 
century. 
 Much later at the seventeenth century the word mellitus from 
alatin word meaning honey was added because of the sweety 
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nature of the urine. At mid 18th century, diabetes was described as 
systemic disease rather than renal disease(2). 
In 1893, pancreatic islets cells were named after 
Langerhans, and in 1909 the name insulin was given to pancreatic 
glucose lowering substance. 
Insulin was first discovered in 1921 by collaborative work, a 
Toronto Leay by Best C.H, J Mcled JR Banting FG1 and Collip. JB, 
Ted Ryder was first child to be treated with insulin(3).  
1.1.3 Classification of types of diabetes:- 
Diabetes as recreantly been classified as follows:-   
1- Insulin dependent diabetes mellitus (IDDM):  
- Low or absent levels of circulating endogenous insulin, 
dependent on injected insulin to prevent ketosis and 
sustain life. 
- Onset predominantly in youth but can occur at any age. 
- Associated with certain human leukocyte antigen (HLA) 
and glutamic acid decarboxylase (GAD) antibodies. 
- Abnormal immune response, islets cells antibodies are 
frequently present at diagnosis. 
- Cause probably only partially genetic, only about 35% 
of monozygotic twins are concordant for IDDM(4).  
2- Non insulin dependent diabetes mellitus (NIDDM): 
 3
- Insulin levels may be normal, elevated, or depressed, 
hyperinsulinemia and insulin resistance characterize 
most patients may develop as the disease progresses.  
- Not insulin dependent or ketosis prone under normal 
circumstances, but may require insulin for treatment of 
hyperglycemia(5). 
3- Gestational diabetes: 
Glucose intolerance that has it is onset or recognition during 
pregnancy associated with older age, obesity, family history. 
4- Other types at diabetes: Include diabetes secondary to or 
associated with pancreatic disease, hormonal disease, drug 
or chemical exposure, insulin receptor abnormalities, and 
certain genetic syndromes.  
1.1.4.1 Insulin dependent diabetes mellitus:- 
1.1.4.1.1 Epidemiology of type1 DM:- 
In the United States, the prevalence of type 1 diabetes 
among school age children is about 1.9/1.000. The frequency 
tends to increase with age. This varies from 1 case / 1430 children 
at 5yrs, to 1 in 360 children at 16 years. 
Girls and boys are almost equally affected. There is no 
apparent correlation with socioeconomic status. Peaks of 
presentation occur in two age groups, 5-7 years and at puberty. 
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It is reported that an incidence of 5.9/100/000. Most recent 
study showed that incidence is 10.1, 100.000 Sudanese children 
under 15 years of age(6).  
1.1.4.1.2 Family studies:- 
In 493 families studied after identification of proband with 
IDDM, the risk of IDDM in siblings was higher (8.5%). If the 
proband had been diagnosed before age 10 than if he or she had 
been diagnosed after age 10 than if he or she had been diagnosed 
after age 10 (4.6%). 
Only 5 – 10%  of families had one or more siblings or parents 
with IDDM. 
An evaluation of studies involving 9000 families revealed         
a mean risk for diabetes 1.3% in parents, 4.2% in siblings, and 
1.9% in off spring. 
Although slightly higher estimates have come from other 
studies, familial transmission of IDDM is not common(7). 
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1.1.4.1.3 Inheritance:- 
? The mode of inheritance of type I DM is unknown.  
? A dominant mode of inheritance has been suggested, but the 
variety of IDDM in parents, siblings, and off spring of affected 
subjects exclude simple dominant inheritance. 
? Recessive inheritance is suggested by the high frequency of 
HLA identify in concordant siblings with type I DM but against 
the recessive theory is the fact that homozyosity for HLA-
DR3 or DR4 allele doesn't increase the risk for diabetes(8). 
1.1.4.1.4 Possible environmental triggers: viruses  
Mumps virus, Rubella, cytomgalovirus, coxsackviruses 
Retroviruses, Reoviruses, encephalomyocarditis virus. 
Viruses could trigger beta cell destruction through three 
mechanisms(9):- 
1- Direct cellular destruction by a betacyto tropic virus. 
2- Generation of cytokines that damage beta cells. 
3- Molecular mimicry. 
• Congenital Rubella appears to induce diabetes in about 20% 
of affected persons in the United States, and Australia, if the 
affected child is DR3 or DR4, the prevalence increase to 
40%. 
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• Coxsackie virus B4 was isolated from patient who died in 
ketoacidosis with apparent post infections diabetes, probably 
the consequence of fulminating beta cell destruction(10). 
• Molecular mimicry: refers to an immune response to a viral 
protein that has an amino acid sequence homology with a 
beta cell protein and that theoretically induce antiviral CD8 
lymphocyte to react with beta cells. For example a 24-
aminoacid epitope of the glutamic acid delaboxylase of beta 
cells is highly homologoms to adominan protein of diabetes 
genic coxsackieisms B4(11). 
1.1.4.1.5 Is type1 DM an immune mediated disease? 
The evidence that type I DM is an immune mediated disease are:- 
1- Type I DM is linked with class II (D-region) antigens known 
to be associated with autoimmune disease. 
2- Type I DM may occur with other forms of immune 
endocrinopathy, such as Hashimoto’s thyroiditis, adrenal 
insufficiency, with pernicious anemia, Myasthenia gravis, and 
vitiligo. 
3- The coupling of diabetes with immune endocrinopathy may 
cluster in families(12).  
4- An early lesion in diabetes in both animals and humans is 
lymphocyte infiltration of the islets of langerhans (Insulitis or 
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isletitis) that resembles lymphocytic infiltration of other 
autoimmune diseases.  
5- Antibodies directed against both cytoplasmic and cell surface 
determinants on islets cells are present in many type I 
diabetic subjects at diagnosis. 
6- The compelling evidence is that rapid development of isletitis 
and destruction of beta cells occur in pancreases 
transplanted from unaffected monozygotic twins into twins 
with diabetes(13). 
1.1.4.1.6 Pathology of islets of langerhans in type1 DM:- 
Early pathology: 
Infiltration of the pancreatic islets of patients with type I IDDM by 
lymphocytes and macrophages is termed insletitis, it is present in 
two thirds of diabetics studied at autopsy within 6 months after 
initial symptoms. Lymphocytic infiltration of the pancreas in type I 
IDDM can also be demonstrated with the use of radio-labeled 
lymphocytes and scanning techniques. Isletitis may be a result of 
subtotal islet injury rather than its cause focal regeneration of beta 
cells occur soon after the onset of diabetes but less frequently as 
the disease progresses(14).      
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Late pathology:- 
The reduction in pancreatic weight in subjects with type I 
diabetes at atopsy is caused by atrophy of exocrine tissue which 
constitutes about 98% of pancreatic volume. The atrophy may 
result from loss of the high levels of insulin that perfuse the acinar 
tissue through the pancreatic vasculature and that may exert 
atrophic effect on acini. 
The islets in IDDM are fewer and often smaller than normal, 
averaging less than one third of the volume in non-diabetic 
controls or in patient with type II DM, beta cells are virtually 
absent, and the islets consist almost entirely of alpha and delta 
cells.  
The number of alpha and delta cells per islet is normal or 
increased, and the total alpha and delta cell mass per-pancreas is 
within normal range(15). 
1.1.4.1.7  Hormonal pathophysiology of type1 DM:- 
- In diabetes insulin deficiency causes a rise in glucagon 
concentration, the decreased insulin / glucagon ratio 
increases production of glucose by the liver, insulin 
deficiency impairs glucose utilization by insulin requiring 
tissues, activates lipolysiss, enhance proteolysiss, enhance 
ketone production(16).   
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- Increase secretion of epinephrine, nor epinephrine, cortisol, 
growth hormone, B-endorphin, angiotensin and vasopressin 
may play a role in development of ketoacidosis(17). 
1.1.4.2 Clinical features:- 
Type I DM: 
1- Uncomplicated onset. 
2- Diabetic ketoacidosis. 
Clinical manifestation:- 
1- Uncomplicated onset: classical presentation of diabetes in 
children is history of polyuria, polydipsia, polyphagia and 
weight loss. The duration of these symptoms varies but is 
often less than 1 month. 
2- A clue to the existence of polyuria may be the onset of 
enuresis in a previously toilet-trained child. 
3- Lethergy, weakness, and weight loss is common. 
4- Pyogenic skin infection and monilial vaginitis in a dolescent 
female may be present at the time of diagnosis. 
1.1.5 Diabetic-ketoacidosiss:- 
DKA exists when there is hyperglycemia (glucose greater 
than 300 mg/dl) ketonemia, acidosiss PH less than 7.3 and 
bicarbonate less than 15mEq/L, glucosuria, and ketonuria in 
addition to clinical features of diabetes. 
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Precipitating factors for DKA:- 
- Stress such as trauma.  
- Infections. 
- Vomiting. 
- Psychologic disturbance.    
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1.2.1 Normal and aberrant growth  
1.2.1.1 Normal growth:  
Growth is common to all multinuclear organisms and occurs 
by cell replication and enlargement, along with the non- 
homogenous processes of cell and organ differentiation. The over 
all morphologic development systems at different times, are 
determined by the genetic composition of the individual 
imperatives with external factors, including nutrition and 
psychosocial and economic factors. 
In children deviation from a normal pattern of growth can be 
the first manifestation of a wide variety of disease processes, 
including both endocrine and non endocrine disorders and 
involving virtually any organ system of the body(18). 
The peak height velocity during the pubertal growth spurt is 
comparable to the rate of growth during the second year of life. 
Karl Berg and colleagues have resolved the normal linear 
growth curve into three additive, phases. The components of this 
model include an infancy phase, starting in the midgestation and 
then rapidly decelerating to about 3 to 4 of age. 
A childhood phase slowly decelerating during early 
adolescence and sigmoid shape puberty phase, that involve 
adoloscent growth spurt(19).  
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1.2.1.2 Skeletal maturation (bone age):   
The growth potential in the tubular bones can be assessed 
by evaluation of the progression at ossification centers of the 
skeleton appear and progress in a predictable consequence in 
normal children, and skeletal maturation can be compared with 
normal age related standards. This forms the basis of bone age or 
skeletal age which readily quantitative determination of net somatic 
and is mirror of the tempo in growth and maturation. It is not clear 
what factors determine this normal maturation pattern, but it is 
certain that genetic factors and multiple hormones including 
thyroxine, GH, and gonadal steroids are involved(20). 
A radiograph of the left hand and wrist is used for 
comparison with standard of Greulich and Pyle. The hand is used 
because radiograph of entire skeleton would involve additional 
radiation exposure, and hands don't contribute to height. 
1.2.1.3 Endocrine regulation of Growth:- 
Pituitary is the master gland controlling the endocrine activities of 
the body. It is central to understanding the regulation of growth 
embryologically the pituitary gland is formed from Rathke's pouch 
which gives rise to adenohypophysis and neurohypophysis which 
originates in the neural ectoderm of the forebrain.  
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Growth hormone producing cells identified in adenohypophysis 
by 9th wk of gestation, and a vascular connections between the 
anterior lobe of the puitutay and hypothalamus develop at this 
time. Although hormone production can occur in the pitutary in the 
absence of connections with hypothalamus(21).  
1) Growth hormone:- 
Growth hormone has anabolic actions which is mediated 
through insulin like growth factor peptides, it had 
adiabetogenic actions. Growth hormone has a variety of 
metabolic actions some of which appear to be independent of 
IGF production such as enhancement of lipolysis stimulation 
of aminoacid transport in diaphragm and heart, and 
enhancement of hepatic protein synthesis. (22) 
2) Insulin like Growth factor:-  
IGF-1 levels in human newborn serum are generally 30 to 50%  
at adult level. Serum levels rise during childhood and attain. 
Adult levels at onset of sexual maturation. During puberty IGF-
1 level rise to two to three times to the adult ranges. The levels 
during adolescence. Correlate better with Tanner stage or 
bone age than with chronologic age after adoloscence at least 
after 20 to 30 year  serum IGF, level demonstrate gradual and 
progressive age associated decline(23). 
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3) Gonadal steroids:- 
      Androgens and estrogens do not contribute substantially 
to normal growth before puberty, the adolescent rise in serum 
gonadal levels is an important part of pubertal growth spurt. 
State of androgen or estrogen exciss. Prior to epiphyseal 
fusion cause a rapid linear growth and skeletal maturation. 
Replete state is obligatory for a normal growth 
response to gonadal steroids and children with GH 
deficiency do not have a normal growth response to either 
endogenous or exogenous androgens. 
Both androgens and estorgens increase skeletal maturation, 
and that androgons act in this after conversion to estrogen by 
aromatase in extra-glandular tissues, women with and 
estrogen receptor varients have increase height because 
associated tall stature and open epiphyses(24).  
4) Thyroid hormone:  
Thyroid hormone is a major contributor to postnatal growth, 
although relative little importance to growth of the fetus 
hypothyroidism postnatally can cause profound growth failure 
and virtual arrest in skeletal maturation, in addition to direct 
effect on epiphyseal cartilage, thyroid hormones. Appear to 
have permissive effect on growth hormone secretion  
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Patient with hypothyrodism have deceased spontaneous GH 
secretion and blunted responses to GH provocation tests. 
Treatment with thyroid hormone result in rapid catch-up 
growth, which is accompanied by skeletal maturation, causing 
rapid epiphysed fusion and compromise of adult height. (22)  
                                                
1.2.1.4 Growth retardation: 
Classification at growth retardation disorders either: 
1) Primary growth abnormalities. 
2) Secondary growth disorders. 
3) Idiopathic short statue. 
1.2.1.5   Secondary growth disorders: 
1) Malnutrition: Inadequate caloric or protein intake or both is 
the most common cause of growth failure. In Marasmus and 
kwashiorkor deceased weight preceeds the failure of linear 
growth by short time. 
Both acute and chronic malnutrition affects the GH-IGF 
system. Undernutrition may also be voluntary as with dieting 
and food fads caloric restriction is common in girls during 
adolescence when it may be associated with anxiety 
concerning obesity, anorexia nervosa and bulimia which 
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leads to impaired growth prior to epiphyseal fusion that may 
result in diminished final adult height(25). 
2) Malabsorption: 
Growth retardation may predate other manifestations of 
malabsorption or chronic inflammatory bowel diseases or 
both. 
In celiac disease (gluten induced enteropathy) impaired 
linear growth may be the first manifestation of the disease 
although the degree of growth impairment may be similar in 
patients with and those without gastrointestinal symptoms(26). 
In European studies celiac disease is the cause of 
unexplained growth impairment in 5 to 20% of unselected 
patient. The onset and progression at puberty may be 
delayed and menarche may be late. 
Screening test for celiac disease is needed to obviate the 
standard diagnostic tests involving multiple intestinal 
biopsies when assessing asymptomatic patient. 
Both IgG and IgA antigliadin, antiendomysial and antijejunal 
antibodies have relatively high sensitivity and specificity(22). 
Some have recommended jejunal biopsy to rule out celiac 
disease in all cases of unexplained growth failure during the 
first 5y of life, an alternative is to reserve biopsies for children 
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with history of dirrhoea or steatrrhoea or both in first 2y of 
life, abnormal D-xyloses absorption tests, and IgG or IgA 
antigliadin antibodies. Gluten withdrawal is highly effective 
treatment and result in rapid catch up and decreased clinical 
symptoms during the first 6 to 12 months of treatment(27). 
Low IGF1 and IGFBP-3 levels return to normal during this 
period most children who receive appropriate dietary 
management achieve a normal final height.                               
3) Diabetes mellitus: 
Although weight loss may occur immediately before onset of 
clinically apparent insulin dependent diabetes mellitus, children 
with newly onset diabetes are frequently taller than their pear 
group, possibly because growth hormone and insulin level are 
increased during preclinical evaluation of the disease. Most 
children with IDDM grow normally even those with marginal control 
especially in pre-pubertal years, although growth velocity may 
decrease during puberty(27). 
Growth failure however can occur in adiabatic children with 
long standing poor glycaemic control.  
The mauriac syndrome describes children with poorly 
regulated IDDM severe growth failure, and hepato-splenomegaly 
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due to excessive hepatic glycogen deposition. This growth 
retardation has become increasly rare. 
Growth in diabetes is affected by many pathophysiologic 
processes, including: 
1- Malnutrition. 
2- Chronic intermittent acidosis. 
3- Increase glucocorticoid production. 
4- Hypothyroidism. 
5- Impaired calcium balance. 
6- End organ unresponsiveness to either growth 
hormone or insulin like growth factor(28). 
7- Celiac disease.  
A Longitudinal study of 46 children whose diabetes began 
before the age of 10 years indicated that initial height at diagnosis 
was normal and that the final height SD scores were minimally 
reduced from those at the onset, despite delay of about 2.5 years 
in the onset at puberty in boys, total pubertal height gain was 
diminished and the age of menarche was delayed, the effects of 
altered insulin and IGF-1 level on ovarian function have not been 
assessed in such patients(29). 
Other cause of secondary growth retardation:  
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Renal disease, Chronic liver disease., Hematologic disorder, 
Pulmonary disease and hypothyroidism 
1.2.1.6 Diabetes and growth: 
Over the last 50 years the prognosis for growth and pubertal 
development in children with type I diabetes mellitus has improved 
considerably. The early reports at Mauriac's syndrome were 
related not only to relative deficiency of insulin but also reduced 
caloric intake. Improved insulin delivery and liberalization of caloric 
intake improved insulin delivery and liberalization at caloric intake 
has resulted in improved growth, but subtle abnormalities persist. 
The frequently reported increase height at diagnosis may relate to 
prior hyperinsulinaemia and genetic background with respect to 
IDDM the insulin gene VNTR(30). 
Intensification of insulin therapy may result in leptin 
resistance and excessive gains in fat mass particulary in girls. 
Although it is likely that most children with type I IDDM will have 
normal final heights this excessive weight gain in girls may lead to 
problem with compliance further more, hyperinsulinaemia in these 
subjects may also leads to ovarian hyperandrogenism, increased 
early risk at microvascular complication and long-term risk of 
cardiovascular disease(30).  
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In 2002  in a study of stature at time at diagnosis at type I 
DM. 451 children were examined in pediatric diabetes clinic and 
used data from the National Health and Nutrition examination 
survey for 10522 children as control group The results showed that 
children < 1 year of age were shorter than their peers by 1 SD 
where as those from 3 years to near puberty were taller by 
approximately 0.3 SD with conclusion that taller children generally 
seem to experience increased risk for development at diabetes 
mellitus, except perhaps during infancy or early adolescence(31).  
Elmain A, Hussein O, in Sudan conducted a study of growth, 
puberty, and final height in children with type 1 diabetes,. Acohort 
of  72 Sudanese diabetic children, 7 – 13 years of age at diagnosis 
was followed longitudinally from the onset of diabetes until The 
attainment of final height, standard deviation scores (SDS) at 
diagnosis were 0.04 in boys. And -0.15 in girls, which was greater 
than their genetic height (GTH), the growth velocity between 
diagnosis and final height was slow, with significant reduction in 
pubertal growth spurt, the mean final height attained by these 
children was lower than their GTH. 
The average age at menarche in girls was (15.1 years) and the 
mean Of full sexual maturation in boys was (17.2 years) were 
significantly delayed in this group of diabetic patients, The majority 
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of these patients were thin at diagnosis of diabetes, with median 
body mass index (BMI)<22.(32) 
Heinz E, Roll Rw, et al, conducted a study of development of 
height and weight in children with diabetes mellitus, in a cross-
Sectional sample of 89 children with IDDM for more than 3 years, 
they found the relation of height to weight to be significantly 
different compared to  102  healthy school children of similar age, 
they initiated a longitudinal study and followed children from The 
onset of diabetes for 3 years, recording height, weight, and bone 
age as well as glycoslated hemoglobin and daily insulin 
requirement, They found at diagnosis SDS was identical in 
children with IDDM (+0.04 +/ -0.10) Compared to control children (-
0.07 +/-0.10; m+/-SE) while weight SDS was (-0.26 +/-0.10) in 
children with diabetes (control: +0.01 +/-0.01), Bone age was 
identically retarded in  newly diagnosed IDDM  children (-0.73 +/-
0.12 SDS) .(33) 
Stipancic G, La. Grasta et al, studed growth disorders in children 
with type 1 diabetes mellitus over five – years long observation, 
they found that diagnosed children were taller than their peers, this 
was specially referred to age groups between 4 – 9.5 years. 
Weight of the patients and healthy control did not differ. The 
diabetic children had substantially lower weight in puberty than 
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healthy control, BMI was significantly lower in the group of 
diagnosis children on the whole and in puberty, during five – years 
long observation patients have had a significant retardation of 
growth, that retardation referred primarily to patients pre puberty, 
there were significant differences of anthropometric variables 
between those suffering from type 1 DM and their peers, the 
different depend on the age at onset, the disease had a negative 
effect on growth with onset in pre puberty, were as in puberty 
growth was satisfactory. .(34)  
Roll RW, Teller WM et al in University Children Hospital ullm, 
Germany in 1994, studied Genetic influences on height and weight 
in pediatrics patients with IDDM. Measurements of  height and 
weight as well as bone age in unselected group of 389 patients 
with IDDM treated at one institution, in order to identify genetic in 
influences` on these parameters, height and weight were 
determined in 186 unaffected siblings and 177 pairs of parents, at 
diagnosis patients were slightly taller than average (median Z 
score; +0.37). during the subsequent course of diabetes, age – 
adjusted heights decreased progressively for the first 9 years, 
catching up again after more than 10 years of diagnosis. Bone 
ages were progressively retarded  with increasing duration of 
diabetes, in 76 patients of 18 years older, median Z score for 
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height was + 0.30 not different from their unaffected siblings 
(median Z score: +0.22), the correlation with mid parental height 
was identical for diabetic and non diabetic siblings (r = 0.43), in 
contrast children with diabetes were significantly heavier (Z score 
for weight: +0.74 compared to + 0.34 unaffected siblings; P< 
0.002), obesity developed primarily during and after puberty.(33). 
One of the main difficulties in managing type I diabetes in the 
young is nutritional treatment. In study done by Grylli, V. Karwart 
Z, in 2003. Show that adolescents particularly girls and young 
women have increased risk for clinical and sub-clinical eating 
disorders. Adjustment to the nutritional regimen and, to the 
management of the disease in adolescence seems to involve a 
complex interplay of various psychosocial and biological 
aspects(34). 
Barton D.M, Buch H.N, et al. Assessed the process of clinical 
care and outcome of young patients with diabetes mellitus 106 
patients, with age 12-22 years, they found that the mean 
attendance rate was 7.8%. the admission rate was 91 admission 
per 1000 patients years the mean HbA1c was 8.8 and there was a 
significant increase in obesity with mean weight for height at 
diagnosis increasing from 89% to 111% after 7 years of diabetes 
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screening for complication and associated conditions was variable 
64% had thyroid dysfunction, 22% had celiac disease (35). 
In 2003 in Zech republic, Rakosnikova V, evaluated the 
prevalence and natural course of autoimmune thyroid disease in 
diabetic children. They found mild elevation of thyroglobulin auto 
antibodies and peroxidase auto antibodies (>100, <1000M/U/C) in 
19 patients (17% buys: girls 1: 2.2) out of these only 2 had 
increased thyroid volume and or abnormal echo texture. All 
patients remained on thyroid sub-clinical hypothyroidism 
developed within the observation period in nine of them boys: girls 
2:1, she concluded that autoimmune thyroid disease was found in 
28% children and adolescents with type I DM, elevated antibodies 
were associated with early risk of sub-clinical hypothirodism.  
They found in their study the risk of clinically silent celiac 
disease is increased in various autoimmune conditions, which is to 
be found in 2.5% of patients with insulin dependent diabetes 
mellitus or autoimmune thyroid disease, and it is one of 
contributing factor of growth failure of patient with diabetes 
mellitus(36). 
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1.3.1 Puberty and sexual maturation: 
Puberty is a phase in the continum of development of 
hypothalamic –pituitary– gonadal function from fetal life, through 
puberty, to attainment of full sexual maturation and fertility. By 
puberty, secondary sexual characteristics and the adolescents 
growth spurt result in the striking sexual dimorphism of mature 
individuals, fertility is achieved and profound psychological effects 
ensured. These changes are a consequence of stimulation of 
gonads by pituitary gonadotropins and increase in gonadal steroid 
out put. 
Adolescence is accompanied by the onset of adult patterns 
of sociosexual and economic behaviour(37). 
Genetics factors play an impenitent role in the onset of 
puberty, secondary sexual development occurs earlier in black 
girls than in white girls in United States and there is apparent effect 
of social and economic factors. 
Thus when nutrition, health, and infant care are good the 
onset at puberty is determined largely by genetic factors. 
1.3.1.1 Physical changes of puberty:  
Secondary sexual characteristics stages at puberty are 
based on the descriptions of Tanner (1962) using standard rating 
on scale of 1 to 5. 
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Another centile values by Tanner and White House (1976) 
the 97th centile represents the early age limit at which only 3% of 
children will show the feature and 97% remain to do so, and 
conversely the 3rd centile being the late and at normal age range. 
In boys genital development and pubic hair are used in 
assessment of puberty. 
In girls breast development and pubic hair are used in 
assessment at puberty(38). 
1.3.1.2 Boys: Genital development Stages: - 
Stage 1: preadolescent: The testes, scrotum and penis are of 
about the same size and proportions as in early children. 
Stage 2: enlargement of the scrotum and testes, the skin of the 
scrotum redness and changes in texture little or no enlargement of 
the penis. 
Stage 3: lengthening of the penis further growth of the testes and 
scrotum. 
Stage 4: increase in breadth of the penis and development of the 
glans. The testes and scrotum are larger, the scrotum darkens. 
Stage 5: adult. 
Boys: pubic hair: 
Stage 1: preadolescent: No pubic hair. 
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Stage 2: sparse growth at slightly pigmented downy hair chiefly at 
the base of the penis. 
Stage 3: Hair darkens, coarser and more curled, spreading 
sparsely over the junction of the pubes. 
Stage 4: Hair adult in type, but covering a considerably smaller 
area than the adult. No spread to the medial surface of the thighs. 
Stage 5: adult quantity and type with distribution of a horizontal 
pattern and spread up. 
1.3.1.3 Girls breast development: 
Stage 1: preadolescent: elevation of the papilla only.  
Stage 2: Breast bud stage elevation of the breast and papilla as a 
small mound. Enlargement at the areola diameter. 
Stage 3: further enlargement and elevation of the breast and 
areola, with no separation of their contours. 
Stage 4: projection of the areola and papilla above the level of the 
breast. 
Stage 5: mature stage, projection of the papilla alone due to 
recession of the areola. 
Girls pubic hair: 
Stage 1: preadolescent: No pubic hair. 
Stage 2: sparse growth of slightly pigmented downy hair chiefly 
along the labia. 
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Stage 3: Hair darker, coarser and more curled, spreading sparsely 
over the junction of the pubes. 
Stage 4: Hair adult in type, but covering a considerably smaller 
area than in the adult. No spread to the medial surface of the 
thighs. 
Stage 5: Adult quantity and type with distribution of a horizontal 
pattern and spread to the medial surface of the thighs. Spread up 
lines able is late.        
1.3.1.4 Testicular size:  
This can be assessed by comparison with a Prader 
orchidometer (Zachmann et al 1974) either visually or by palpation. 
Frequently information required whether the testis has grown 
to a larger than prepubertal size (1-3ml) and testis volume in 
excess of 4 ml or more  is a good indication that puberty has 
started. Progress through puberty can be monitored according to 
testicular size, but variations in this normal individuals at any stage 
of puberty are so great as to render such, precise observations of 
little aid, and the adult testis varies between 12 and 25ml. 
    There was only centiles for age acquisition of two testicular 
volumes (4mL and 12mL) shown in (Tanner and White House 
1976). 
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1.3.1.5 Breast development:        
    It is not infrequent for one breast to develop earlier or faster than 
the other and staging would be accorded to that of the more 
advanced breast. 
 Difficulties in breast rating may be experienced in obse children, 
though careful examination should distinguish between true breast 
tissue and adipose tissue. 
   Single observation may occasionally make distinction between 
stage 3 and 5 difficult, and a few girls never show stage 4 passing 
straight from stage 3 to 5, and a few other do not advance past 
stage 4. 
1.3.2 Other sexually dimorphic physical changes: 
   In males during puberty larynx, circothyroid cartilage, and 
laryngeal muscles enlarge, the voice breaks at approximately        
13.9 years and the adult voice is a chained by about 15 years. 
 Facial hair in boys first appears on the corners of the upper lip and 
the upper cheeks and then spreads to the midline of the lower lip 
and finally, to the sides and the lower border of the chin the first 
stage of facial hair development usually occurs during pubic hair 
stage 3, and last stage occurs after pubic hair stage 5. 
  Axillary hair appears at 14 years in boys. 
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A total of 93% of black girls and 68% of white girls have axillary's 
hair by age 12. Axillary's sweat glands begin the function as the 
hairs appear cacuminal hair usually appears prior to axillary hair in 
boys(38). 
1.3.3 Menarche: 
   Usually occurs during the 6 months preceding or following the 
fusion of the second and first distal phalanges and the appear of 
sesamoid bone. 
  Anovulatory cycles are common in the first years after menarche, 
Apter and Vinko reported a prevalence of 55% anovulation in the 
first 2 years after menarche, that decreased to 20 % anovulatory 
cycles by the fifth year(35).  
1.3.4 Diabetes mellitus and puberty: 
    Children with IDDM usually require an increase in the dose of 
insulin for glucose control at puberty, the cause of insulin 
resistance is attributed to increased for oxidation. Insulin sensitivity 
is related both to pubertal stage and BMI. 
 In a longitudinal study insulin sensitivity inversely correlated with 
BMI, decreased with pubertal progression from pubertal stage 2 to 
stage 3, and was lower in girls than boys at either stages 2 or 
stage 3. 
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 In well managed children with type I DM the growth rate may 
decreased slightly in the 10 y after diagnosis, slowing of bone 
advancement during this period leads to transient slowing of 
development, but the effect of diabetes mellitus on growth is less 
than the influence of parental height. 
While growth velocity in diabetic children increases again during 
puberty weight gain increases even more during puberty leading to 
high incidence of obesity in children with IDDM(39). 
One study reported a decrease in final height if the diagnosis of 
IDDM was made prior to 5 y of age but not if the diagnosis of 
IDDM was made latter, the pubertal growth rate was reduced in all 
patients particularly in girls. 
 Obese teen-age girls with prominent abdominal adiposity have 
insulin resistance. Abdominal adiposity at prepubartal state is 
associated with early puberty, early menarche. 
  Retinopathy in IDDM appears in teen age year or later, but the 
duration and degree of diabetes control in prepubartal years are 
contributing factors, retinopathy can occur in the prepubartal years. 
The American diabetes association recommends screening for 
microalbuminuria as an index of development of diabetic 
nephropathy. Microalbuminuria can develop early in puberty. 
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In 2002 Hamilton J , found that metabolic control of them worsens 
during the pubertal years in individuals with type1 diabetes 
mellitus. 
This may be due in a part to development trasition from 
dependency on parents to a more autonomous life style. 
Adolescence in also marked by challenging of authority figures and 
previous ways of thinking, experimentation and, in some female 
teenagers emergence of disordered eating attitudes and 
behaviors. The insulin resistance of puberty may be particularly 
maladaptive for the teenager with type I DM and in likely under 
recognized(40).        
Amna M.S, Elfaki, studied age at menarcheal and sexual 
maturation in 612 Khartoum school girls. She found that breast 
enlargement is first sign of puberty starts at mean age of 11 years 
and one month, followed by pubic hair, the average menarcheal 
age for the group studied is comparable to current African means, 
she recommended Sudanese local reference standards for height 
and weight (41). 
Thyria A.E.M, studied menarcheal ages sexual maturation 
among urban, suburban and rural Sudanese girls. She found that 
mean menarcheal age was found to be 13.52, 13.58, 12, 79 for 
rural, suburban and urban girls respectively. High percentage of 
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girls from rural, suburban areas have their weights and heights 
below the 5th percentile compared to urban girls in whom the 
percentiles of those having weights and heights above the 50th 
percentile is more (42).  
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JUSTIFICATION 
 
1. Diabetes mellitus is a common health problem with 
increasing prevalence, among children worldwide. 
2. Diabetes mellitus contribute to be a cause of secondary 
growth failure, delayed puberty in children with type1  DM 
3. One of the main difficulties in managing type 1 DM in young 
is nutritional treatment.   
 
 
 
 
 
 
 
                                   
 
 35
OBJECTIVE 
 
1. To asses physical growth of children with type1 DM, the age 
of onset of pubertal characteristic in adolescent, 
meneracheal age of female  with type1 DM. 
2. To study the associated factors that affect growth in patients 
with type1 DM. 
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Chapter two 
MATERIAL AND METHODS 
2.1. Study design:  
    Across sectional hospital based study. 
2.2. Study area: 
   The study was conducted in Khartoum State in two main diabetic 
referral clinics of:     Gaffer Ibnof Hospital & Jabir Abo Eleiz center.  
2.3. Study duration:  
   The data was collected over 6 months from March to August 
2006. 
2.4. Study population: Children in age group 1-17 year. 
2.5. Sample size: 
          The statistical form used to calculate the sample size was: 
N = Z2 P Q      = 138 
           D2  
N : sample size 
P: prevalence 
Q: probability of failure  
Z: statistical certainty (1.96) 
D: desired margin of error (0.05) 
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138 patients aged 1-17 year fulfilling the inclusion criteria on the 
study area were enrolled in this study. 
2.6. Inclusion criteria: all patients with diabetes mellitus aged 1-
17 year and using insulin were included in this study  
2.7. Exclusion criteria: 
- Patient has NIDDM 
- Patient less than 1 year and more than 17 year 
- Any patient with chronic disease: sickle cell anemia, chronic 
renal failure, skeletal deformities, congenital malformation, 
that affect growth. 
2.8. Study tools:  
1. Questionnaire  
2. Physical examination. 
3. Laboratory investigation. 
2.9. Study technique: 
? Consent was obtained from all parents and children 
included in this study. A questionnaire containing personal 
history, duration of diabetes mellitus number of DKA and 
hospital admissions, doses of insulin per day, compliance 
to management and diet, family history of DM, schooling, 
presence of school service, social background and parent 
education. 
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? Growth parameters according to the NCHS were plotted to 
all participant, anthropometry :-   
1. Weight: the children were weighed with light dresses and 
without shoes, the WT measured in Kg and the reading taken 
to the nearest 0.1 Kg, the WT expressed in Z score and 
compared to the international NCHS standard. 
2. Height: taken without shoes with the child standing with heels 
and back in contact with an upright wall using height 
stadiometer, the height measured in Cm and the reading 
taken to nearest 0.1 Cm, the height expressed in Z score and 
compared to the international NCHS standard.  
(Z score or standard deviation SD score = is deviation 
of the value for an individual from the median value of 
the reference population divided by the standard 
deviation of the reference population). 
3. Body mass index: Wt(kg)/ Ht(m2 ) compared to charts : (5% - 95%) 
A. Under weight: BMI for age or weight for length 
less than 5th percentile. 
B. Over weight: BMI for age or weight for length 
85 – 95th  percentile. 
C. Obese: BMI for age or weight for length more 
than 95th percentile.      
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? Measurement of maturation: Each patient who is age 9-17 year 
was examined in private room (genital and pubic hair for male), 
(breast and pubic hair for female) by comparison their body to 
the drawing of the Tanner stages, using standard rating on 
scale 1-5, which show the centile distribution of the ages which 
the various stages occur, the 97th centile represents the early 
age limit at which only 3% of children will show the features and 
97% remain to do so and conversely the 3rd centile being the 
late end of the normal range.   
? A one ml of whole blood was taken from patient in EDITA 
containers and measured by ion exchange and photometry 
(sensitivity < 4.3%) for HbA1c. 
? Skeletal maturity was assessed by bone age by x-ray of left 
wrist and hand each picture being desired and age to which it 
must closely corresponds within normal population according to 
atlas of Pyle and Greulich (1971). 
? Venous blood sample were withdrawn and assayed for 
determination of thyroid function including free thyroxin (T4), 
thyroid stimulating hormone (TSH) by enzyme linked 
immunoassay (Eliza). Thyroid function test was tested for all 
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patient who had stunted growth delayed puberty and patient 
with goiter. 
2.10.  Case definition:  
     IDDM is referred to all cases of diabetes in which exogenous 
insulin is required to prevent ketoacidosiss regardless of etiologic 
causes. 
- HbA1c indicated good glycaemic control when range between 
6.7 – 7.3%, fair control between 7.3 – 9.1% and bad control 
when > 9.1%. 
- Delayed puberty considered present when the absence of 
physical manifestation of sexual maturation by the age of 13 
yrs in girls and 14 yrs in boys.    
2.11. Statistical analysis: 
     Statistical analysis was performed by statistical package for 
social studies (SPSS) computer programme  pearson chi-square, 
were used for analysis .    
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Chapter three 
RESULTS  
 
Growth assessment was done to the all 138 participant included in 
the study, with a mean age of 11.5 ± 4,2 years (mean ± 
SD);Sexual maturity rate was assessed for children aged 9-17 
years 103 patients (74.6%). 
3.1. Age and gender distribution of type1 DM children and 
adolescents:  
One hundred thirty eight insulin dependent diabetic children and 
adolescents were involved in this study. 71 males (51.4%) and 67 
females (48.6%). Male to female ratio were 1.05:1 with slight male 
preponderance (Fig.1). 
The study group was 1-17 years of age. 8% were 1-5 years age 
group, the majority was 9-17 years old (74.6%) (Table.1) 
3.2. Distribution of type1 DM children and adolescents 
according to region of origin:  
IDDM patients were originally from the central region of Sudan 52 
(37.7%), 18 (13%) were from western region and only 9 (6.5%) 
were from the southern region (Table.2). 
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Table 1: Age groups of diabetic patients in study group 
Variable No % 
1 - <5 
5 - <9 
9 – 17 
11 
24 
103 
8 
17.4 
74.6 
Total 138 100 
 
 
Table 2 :Origin of diabetic patients in study group. 
Variable No % 
North  45 32.6 
Central   52 37.7 
East  13 9.4 
West  18 13 
South  9 6.5 
Non Sudanese  1 0.7 
Total 138 100 
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3.3. Duration of diabetes in the study group: 
Forty nine (35.5%) diabetic patients had the disease for less than 1 
year duration, while 12 (8.7%) had the disease for more than 10 
years (Table.3).   
 
3.4. Frequency of DKA episodes and hospital admission in 
type1 DM children and adolescents:  
Sixty (43.5%) of patients experienced one episode of DKA, 35 
(25.4%) experienced more than 3 episodes of DKA, 55 (39.9%) 
were admitted once to hospital while 39 (28.3%) were admitted to 
the hospital more than 3 times (Table.4). 
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Table 3: Duration of illness with type1 DM in study group. 
Variable No % 
< 1 year 49 35.5 
1- 3 year 27 19.6 
3 – 5 year 25 18.1 
5 – 10 year 25 18.1 
> 10 year 12 8.7 
Total 138 100 
 
 
 
Table 4: DKA episodes and hospital admission of type1 DM 
patients in study group. 
Variable No of DKA (%) No of hospital admission (%) 
Once  60 (43.5) 55 (39.9) 
Twice 26 (18.8) 29 (21) 
3 times  17 (12.3) 15 (10.9) 
> 3 times  35 (25.4) 39 (28.3) 
Total 138 (100) 138 (100) 
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3.5. Frequency of family history of diabetes mellitus: 
Sixty six (47.8%) of diabetic patient had no family history of IDDM, 
while 28 (20.3%) have 1st degree family history of DM, 44 (31.9%) 
have 2nd degree family history of DM (Table.5). 
 
3.6. The level of education in type1 DM patient in study group:  
Twenty two (15.9%) of IDDM participants were not educated 11 of 
them (8%) their age less than 5 years. 1 was university student 
and the majority were basic school level 82 (59.4%) (Table.6). 
3.7 The effect of diabetes mellitus on the school performance 
and attendance: 
Sixty four (46.4%) had regular attendance, when considering 
school attendance 44 (31.9%) were interrupted, 21 (15.21%) of 
study group stopped their education after they developed diabetes. 
When considering school performance after developing diabetes, 
34 (24.6%) deteriorated, 59 (42.8%) they were not affected by the 
disease. 
 
 
 
 
 47
 
 
Table 5: family history of type1 DM in type1 DM children  
Variable No % 
+ve 1st degree  28 20.3 
+ve 2nd degree 44 31.9 
-ve  66 47.8 
Total 138 100 
 
 
Table 6: level of education in type1 DM patients 
Variable No % 
Not educated  22 15.9 
Basic school 82 59.4 
Secondary school 33 23.9 
Higher education 1 0.7 
Total 138 100 
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3.8  Management of DM in children and adolescents – insulin 
and compliance:- 
The majority of patients 130 (94.2%) who participated in the study 
were on twice daily dose system, while 5 (3.6%) on one dose 
system, and 3 (2.2%) participants were using more than two doses 
per day. 
Eighty-three (60.1%) taking, 0.5 - 1u/kg/day and 13 (9.4%) had 
less than 0.5 u/kg/day and 3 patients had more than 2 IU 
insulin/kg/day. 
One hundred and nine (79%) of IDDM patients complied with their 
dose of insulin. of Non-compliance was found in 29 (21%) 
(Table.7).  
Financial inability was found to be the most frequent 12(41.4%). 
Many 5(17.2%) were not adherent to their dose because of 
ignorance of the child and/or his family. 12(41.4%) refused to take 
their doses most probably due to difficult mood associated with 
puberty.   
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Table 7: Current insulin frequency of injection.  
Variable No % 
Once  5 3.6 
Twice 130 94.2 
Three 3 2.2 
Total 138 100 
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3.9 Heights and weights for age distribution percentiles of 
children and adolescents with current type1 DM: 
The diabetic patients showed poor growth matched to 
chronological age that 45 (32.6%) had height less than 5th centile 
for height Figure (2), 54 (39.1%) less than 5th centile for weight, 
and 6 (4.3%) participants was over weight (> 90th percentile) 
(Fig.3). 
 
3.10 Z score distribution for weights and heights of children 
and adolescents with current type1 DM:- 
The diabetic patients showed poor growth as 61 (44.2%) had 
height/ age less than -1 SD, (Fig.4); and in 81(58.9%) weight/ age 
was less than -1 SD (Fig.5).  
The study showed weight/ height score of < -2 SD were found in 
18 (13.0%) participants (Fig.6).  
 
3.11 Body mass index distribution percentiles of children and 
adolescents with current type1 DM: 
 Fifty (36.2%) of diabetic patients showed BMI between 25th – 75th 
and 37 (26.8%) participants with BMI < 5th, 11 (8.0%) had BMI > 
85th with increase risk of over weight and 3 (2.9%) were obese 
(Fig.7) 
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2.12 Glyceamic control (HbA1c) in type1 DM children: 
Seventy one (51.8%) of IDDM patients had poor  glyceamic control  
(HbA1c > 9.1%) only 25(18%) had good  glyceamic control  
(HbA1c < 7.3%) (Table.8). 
 
3.13 Sexual maturity of adolescents with current type1 DM:- 
One hundred and three their age 9 -17 year were examined, most 
diabetic adolescents showed preadolescents stage of Tanner's 
15(28.3%) male and 20(40.0%) female, 5(9.4%) male and 
5(10.0%) female showed Tanner's stage 5. (table.9).  
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Table 8: Glyceamic control in studied patients with type1 DM 
HbA 1c Frequency % 
< 7.3 25 18 
7.3 - < 9.1 42 30.8 
> 9.1 71 51.2 
Total 138 100 
 
 
 
Table 9: Sexual maturity rate of children with current type1 
DM (103) 
SMR (Tanner's) Male (%) Female (%) 
Stage 1 15 (28.3) 20 (40) 
Stage 2 14 (26.4) 6 (12) 
Stage 3 12 (22.7) 7 (14) 
Stage 4 7 (13.2) 12 (24) 
Stage 5 5 (9.4) 5 (10) 
Total 53 (100) 50 (100) 
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3.14. Height in type1 DM children and adolescents:- 
Stunted growth, short stature is height for age <-2SD was found in 
38 patients (27.5%), 32 patients (23.2%) had delayed bone age 
and 24 of them their HbA1C was > 9.1. 
3.14.1. The effect of age in Stunted growth:- 
Sixteen (15.5%) showed HT/age <-3SD in age group 9-17 y, and 
15 (14.6%) showed Ht/Age <-2SD in the same age group. Where 
as 3 (12.3%) in age group 1-<5 years showed Ht/Age <-2SD (P 
=0.121) (Table.10). 
3.14.2. The influence of sex in Stunted growth: 
The results showed that females 20 (55%) were more affected 
than males 18 (45%), there was no statistical significance 
association found (P=0.141) (Table.11). 
3.14.3. The effect of glyceamic control in Stunted growth: 
There was significant association between glyceamic control and 
stunted growth 15 (28.8%) showed HbA1c more than 9.1% 
(P=0.001) (table.12). 
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Table 10: The effect of age in Stunted growth 
Variable 1 -5 Y 5 – 9 Y 9 – 17 Y Total 
Count < -3  
% within age groups 
3 
15.8% 
1 
5.0% 
16 
80.8% 
20 
100% 
Count-3 - -2.01  
% within age groups 
0 3 
16.7% 
15 
83.3% 
18 
100% 
     
 (P = 0.121) 
 
 
Table 11: The influence of sex in Stunted growth 
Variable Male Female Total 
Count < -3  
% within gender  
9 
45.0% 
11 
55.0% 
20 
100% 
Count -3 - -2.01  
% within gender  
9 
50.0% 
9 
50.5% 
18 
100% 
 (P= 0.141) 
 
 61
 
 
Table 12: The effect of glyceamic control in Stunted growth 
Variable      < 7.3 7.3 - <9.1 >9.1 Total 
Count < -3  
% within HbA1c 
0 
 
5 
25.0% 
15 
75.0% 
20 
100% 
Count -3 - -2.01  
% within HbA1c 
1 
5.9% 
5 
27.8% 
12 
66.7% 
18 
100% 
    (P = 0.001) 
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3.15. Weight in type1 DM children and adolescents: 
Weight was affected in patients with IDDM that moderate under 
weight with Z score <-2SD found in 24 (14.4%) and sever under 
weight that Z score <- 3SD found in 9 (6.5%) (fig.5). 
3.15.1. The effects of age on development of under weight: 
Nine (8.7%) show wt/Age <-3SD in age group 9-17 years, and 18 
(17.5%) show wt/Age <-2SD in same age group, where as 3 
patients (12.5%) with age group 1 < 5 years (P= 0.383) (Table.13). 
3.15.2. The effect of sex in under weight in type1 DM patients: 
Although there were 8 (11.3%) males with in gender had wt/Age <-
3SD, and 13 (19.4%) females with in gender, and 11 (15.5%) 
within gender show wt/Age <-2SD there was no statistically 
significant between both sexes (P= 0.331) (Table.14) 
3.15.3. The effect of glyceamic control in under weight: 
There was significant association between glyceamic control and 
underweight (P= 0.002) (Table.15).   
3.15.4. The effect of nutrition in under weight: 
Six (9.05%) of those weight <-3 SD had inadequate nutrition and 
18(28.6%) of those with weight <-2 SD had inadequate nutrition.    
Statistically there was significant correlation between inadequate 
nutrition and under weight in diabetic patients (P= 0.001) 
(table.16). 
 63
Table 13: The effect of age in under weight  
Variable 1 - <5 y 5 –< 9 9 – 17 Total 
Count  -3  
% within age groups 
  9 
100% 
9 
100% 
Count -3 - -2.01  
% within age groups 
3 
12.5% 
3 
12.5%
18 
75.0% 
24 
100% 
      (P = 0.388) 
 
 
Table 14: The effect of sex in under weight  
Variable Male female Total 
Count -3  
% within gender  
8 
88.9% 
1 
11.1% 
9 
100% 
Count -3 - -2.01  
% within gender 
11 
45.8% 
13 
54.2% 
24 
100% 
    (P = 0.331) 
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Table 15: The effect of glyceamic control in under weight  
Variable < 7.3 7.3 - <9.1 > 9.1 Total 
Count -3  
% within HbA1c 
 3 
33.3% 
6 
66.7% 
9 
100% 
Count -3 - -2.01  
% within HbA1c 
3 
12.5% 
6 
25.0% 
15 
62.5% 
24 
100% 
    (P = 0.002) 
 
 
Table 16: the effect of nutrition in under weight 
  
Variable Adequate Not adequate Total 
Count -3  
% within nutrition   
3 
33.3% 
6 
66.7% 
9 
100% 
Count -3 - -2.01  
% within nutrition  
6 
25.0% 
18 
75.0% 
24 
100% 
(P = 0.001) 
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3.16. Skeletal maturation in type1 DM children and 
adolescents: 
Delayed bone age were found to be in 32 patients (23.2%) 
(Table.17). 
3.16.1. The influence of age in delayed bone age: 
It was found that 29 (29%) within age group (9-17 years) and 3 
(9.4%) in age group1 - < 5 years. There was statistically significant 
association between age group and delayed bone age (P= 0.012) 
(Table.18). 
3.16.2. The influence of sex in delayed bone age:  
It was found that 18 (28.1%) females with in their gender, and 14 
(20.3%) males within their gender had significant delayed bone 
age. There was no significant association between bone age and 
sex (Table.19). 
3.16.3. The effect of glyceamic control in delayed bone age: 
There was significant association between glyceamic control and 
delayed bone age (P= 0.001) (table.20). 
3.16.4. The effect of recurrent DKA attacks in delayed bone 
age: 
Fifteen (46.9%) within bone age had more than 3 attack of DKA, 
there was significant correlation between recurrent of DKA and 
delayed bone age (P= 0.003) (Table.21). 
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3.16.5. The effect of nutrition in delayed bone age: 
There was significant association between inadequate nutrition 
and delayed bone age (P= 0.008) (Table. 22). 
 
 
Table 17: Bone age in patients with type1 DM 
Variable Frequency % 
Corresponding to chronological age  106 76.8 
Delayed bone age  32 23.2 
Total  138 100 
 
 
Table 18: The influence of age in bone age in study group  
Variable 1 - <5 Y 5 - <9 9 - 17 Total 
Corresponding  
% within age groups 
7 
6.9% 
23 
22.8% 
76 
70.3% 
106 
100% 
Delayed bone age  
% within age groups 
3 
9.4% 
 29 
90.6% 
32 
100% 
     (P = 0.012) 
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Table 19: The influence of sex in bone age in study group  
Variable Male Female Total 
Delayed bone age 
%within in gender 
14 
43.8% 
18 
56.3% 
32 
100% 
(P= 0.291) 
 
 
 
Table 20: The effect of glyceamic control in bone age in study 
group  
Variable <7.3 7.3 - <9.1 > 9.1 Total 
Delayed bone age 
%within HbA1c 
2 
6.3% 
6 
18.8% 
24 
75.0% 
32 
100% 
(P = 0.001) 
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Table 21: The effect of recurrent DKA in bone age in study 
group 
Variable once twice > 3 times Total  
Delayed bone age 
%within DKA 
12 
36.1% 
5 
17.0% 
15 
46.9% 
32 
100% 
(P = 0.003) 
 
 
 
Table 22: The influence of nutrition in bone age in study 
group  
Variable Adequate Not adequate Total 
Delayed bone age 
%within nutrition  
12 
35.5% 
20 
64.5% 
32 
100% 
    (P = 0.008)  
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13.17. Menarcheal age of of girls with diabetes in studied 
group:  
In the study it was found that the mean menarcheal age of girls 
with diabetes (13.2 year) 
3.18. Delayed puberty in adolescents with type1 DM: 
It was found that 9 males and 10 females didn’t show any signs of 
puberty by the age of 14 and 13 years respectively. 
Statistically there was no significant association between delayed 
puberty and gender,  
In males there was significant correlation between glyceamic 
control and delayed puberty (P= 0.05) (Table.23). 
There was no significant association between recurrent attack of 
DKA and delayed puberty in males(P= 0.258) (Table.24). 
In females there was significant correlation between glyceamic 
control and delayed puberty (P= 0.52) (Table.25). 
Also there was significant correlation between in adequate nutrition 
and recurrent attack of DKA and delayed puberty in females 
(P=0.001), (P=0.002) respectively (table.26,27). 
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Table 23: The effect of glyceamic control in puberty in male in 
study group 
 <7.3 7.3 - <9.1 > 9.1 Total 
Testicular volume <4ml       
               % within HbAIc  
Testicular volume  >4ml         
               % within HbAIc  
 
 
18 
39.1% 
3 
33.3% 
11 
28.3% 
6 
66.7% 
15 
32.6% 
9 
100% 
44 
100% 
(P = 0.053) 
 
Table 24: The effect of recurrent DKA in delayed   puberty in 
males in study group 
 >3 Total 
Testicular volume <4ml       
               % within DKA  
Testicular volume  >4ml         
               % within DKA  
4 
44.4% 
12 
26.1% 
9 
100% 
44 
100% 
(P= 0.258) 
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Table 25: The effect of glyceamic control in delayed puberty in 
females in study group 
 <7.3 7.3 - <9.1 > 9.1 Total 
delayed puberty in females      
               % within HbAIc  
 
 
 
 
3 
33.3% 
7 
66.7% 
10 
100% 
P= (0.052) 
 
 
 
Table 26: The influence of nutrition in delayed puberty in 
females in study group 
Variable Adequate Not adequate Total 
Delayed puberty  
%within nutrition  
2 
22.8% 
8 
77.8% 
10 
100% 
P= (0.001) 
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Table 27: The effect of recurrent DKA in delayed   puberty in 
females study group 
 >3 Total 
delayed   puberty in females       
               % within DKA  
Normal puberty in females       
               % within DKA   
5 
55.0% 
5 
55% 
10 
100% 
40 
100% 
(P= 0.002) 
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3.19. Other association with type1 DM that affect growth: 
Thyroid function test (TSH,T4) was done in stunted patient 38 
(27.5%), it was found that  there were associated thyroid disorder 
(hypothyroidism) in 3 patients all of them were females (table.28).  
 
 
 
Table 28: Thyroid function test in stunted patient with type1 
DM in study group  
Variable Frequency % 
Normal TSH, T4 35 92.1 
  TSH,   T4 3 7.9 
Total  38 100 
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Chapter four 
DISCUSSION 
 
Growth parameters weight, height, BMI, sexual maturity rate, bone 
age, thyroid function tests were chosen because they are easy to 
be used for follow up of patients with type1 DM. and can be good 
indicators to asses growth, diabetes control and for compliance to 
managements. 
4.1 Gender preponderance: 
  The present study revealed slight male preponderance m/f 
ratio: 1.05:1 this result was also obtained by El-Kheir K, reported 
m/f (m/f : 1.6:1), Zaki, reported m/f : 1.3:1, and Mohammed H, 
reported m/f: 1.1:1, and Abdulah MA, in Riyadh, Weber B, in UK 
also showed slight male preponderance. (43,44,45,46,47) 
However female preponderance was reported in the 
literature as in local studies, that Elamin A, on the studying the 
prevalence at diabetes in school age children and Abusamra's, on 
studying children with DKA, as well as that reported by Salman H, 
et al Saudi Arabia who reported m/f: 1:1.2. (6,48,49)  
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These difference in sex preponderance most likely resulted 
from a chance factor that operating in sample selection as 
sometimes some children and adolescents refuse to participate in 
such studies. 
4.2 Origin regional area: - 
The present study revealed that most of our patients 
originated from Central (37.7%) and from North (32.6%) region of 
Sudan. Similar results were revealed by Zaki M who found that 
Arabic tribes constitute (83%) of her study population and most of 
them (58.5%) were from Northern Sudan; Southern region of 
Sudan were not represented in her study, as they represent (6.5%) 
in our series.  
This finding reflects the my migration at northern and 
southern population towards Khartoum and the central regions 
around it. 
4.3 School attendance and performance: -  
Abusamra reported, that 89.7% had regular attendance and 
in contrast Mohammed H reported that only 41% had regular 
school attendance and 7% not educated, 14% stopped education 
after developing diabetes and 38% deteriorate in school 
performance, and Daod O., who showed that 16.7% stopped 
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education after developing diabetes, 1.9% not educated and 
27.5% were deteriorated in their performance. (48,45,50) 
These differences were explained by the differences in the 
age groups at each study, that the preset study takes 1-17 years, 
where Mohammed H. and Daod O., took 6-18 years and 0-15 
years respectively. 
4.4 Insulin dose, compliance and storage: -  
This study showed that 73.2% had adequate storage of 
insulin. 3.6% used single dose per day, 94.2% used two doses per 
day, and 2.2% used more than two. < 0.5 u/kg/day used by 9.4%. 
The majority using 0.5-1 u/kg/day (60.1%) and 2.2% of the 
participants used > 2 u/kg/day.  
These results were not similar to how those reported by 
Abusamra in which 2/3 of her study population used two doses per 
day and 35.8% used single dose, and Mohammed's H, where 70% 
used twice, 26% used once and 4% used more than two doses per 
day, and these result were unlike those reported by Zaki and Daod 
where 56.9% and 91.2% take single dose respectively. These 
differences reflect the tendency towards using multiple dose 
regimen in the last decade. (48,45,44,50)  
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4.5 Glyceamic control in type1 DM: - 
Measuring HbA1c in IDDM in children and adolescents 
enrolled in the study revealed 51.2% had poor control, 30.8% fair 
and 18% good control. The mean HbA1c was found to be 9.7 ± 
2.8. These results were not similar to that reported by Mohammed 
H. where HbA1c was found to be 10.8 ± 3.2, 60% had poor; 24% 
fair and 16% had good control, and Zaki M. who reported 58.8% 
had poor, 32.2% fair and 9% had good control, also Daod O. found 
52% poor control. (45,44,50) 
These result were unlike those reported by Abusamra where 
mean Hb1c was 13.3 ± 3.2 and 82.4% were poor control and only 
one patient had good control, the difference where most probably 
due to the fact that she did her study in uncontrolled patients who 
presented with DKA, also Elamin reported mean HbA1c of 12 ± 
1.9, which is higher than repeated in this study.(49,32)  
This explained by the improvement of diabetic control that 
occurred during the last decade and better management. 
Oslen B in similar study (1999) reported mean Hb1c in 
Danish was 9.7 ± 1.7, only 11% had good control, 
 also Bouhanick B in 2003 reported mean HbA1c in French was 
8.6 + 1.8 and 34% of patients had unsatisfactory control (51,52).  
 78
4.6. Z. score Height /age in children and adolescents with 
type1 DM:- 
In this study height was affected, that ht/age <- 2SD was 
found in (27.5%)of patients, the most affected age group was the 
9-17 years (80.8%). Statistically no significant correlation found to 
sex. Positive correlation was found to age, duration of diabetes, 
glyceamic control and nutrition. 
These results were similar reported by Elamin A, in study of 
72 Sudanese diabetic children with age 7-13 years, he found the 
mean height SDS was 0.04 in boys and –0.15 in girls, the mean 
final height attained by these children was lower than their genetic 
target higher, and these retardation in physical growth was 
positively correlated with duration of diabetes and glyceamic 
control (32). 
Heinz E in Germany found that during the subsequent 
course of diabetes age adjusted heights decreased progressively 
for the first 9 years, catch up again after more than 10 year of 
diabetes, with conclusion that longitudinal growth is temporary 
reduced (33). 
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4.7. Z. score weight /age in children and adolescents with 
type1 DM:- 
In this study weight was affected in patients with type1 DM, 
that WT/age <-3SD in 9 (6.5%), <-2SD in 24 (17.4%) and <-1SD in 
48 (34.8%), the most affected age group was 9 – 17 years (75%) 
<-2SD and (72.9%) <-1SD.  
Statistically no significant correlation was found to sex, DKA 
attacks, positive correlation was found to glyceamic control and 
nutrition.  
This is similar to Elamin A, he found majority of diabetic 
children were thin, but showed remarkable progressive weight gain 
during puberty, the weight gain was independent of weight at 
diagnosis and duration of diabetes but positively correlated with 
daily dose of insulin and HbA1c concentration (32). 
Similar to Heinz E in Germany who found that children with 
diabetes were significantly heavier (Z. score for weight + 0.74 
compared to 0.34) than un affected sibling (p, <002), and obesity 
developed primarily during and after puberty, with conclusion that 
as group, children with type1 DM become significantly over weight, 
which is likely to increase the cardiovascular risk during adult 
hood(33).        
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4.8. Puberty in type1 DM adolescents:- 
In this study we found that 9 (16.9%) male and 10 (20%) 
female of adolescents had a delayed puberty. There was 
significant association to poor glyceamic control, and inadequate 
nutrition. 
These similar to Alamin A, he found the average of 
menarche in type1 DM adolescents in girl (15,1 years) and mean 
age at full sexual maturation in boys (17.2 years) were significantly 
delayed in this group of diabetic patients, this delayed in pubertal 
development is positively correlated with duration of diabetes 
before onset of puberty and glycated hemoglobin concentration, 
with conclusion conventional therapy of diabetic children is 
associated with impairment of physical growth and delayed sexual 
maturation (32). 
4.9. Skeletal maturation in type1 DM children and 
adolescents:-  
In this study was found that 32 (23.2%) had delayed bone 
age. The adolescents was more affected, there was significant 
correlation to glyceamic control and in adequate nutrition. 
This similar to Heinz E in Germany, he found that bone age 
was identically retarded in type1 DM children (-,73+/-,12 SDS) in 
control group of children from same regional background (-0,50+/-
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0,12 N.S), Also Holl RW, found bone age in diabetic children were 
progressively retarded with increasing duration of diabetes. (33) 
Unlike to Wiske  PS, in a study of evaluation of growth in 
young diabetic, he found that bone age was not significantly 
different from chronological age in those who had not achieved 
maturity (14.4 versus 14.5 yr), mean age of menarche was (12.9 
year), 
 When compared to normal the diabetic sample had 
diminished serum calcium and magnesium (0,001) though 
parathyroid hormone were not significantly different, he 
demonstrated that bone mass in juvenile diabetes is depressed, 
without evidence of impaired overall growth or delayed maturation, 
the abnormality in bone growth progresses with disease but dose 
not appear vary with serum glucose control, there is minimal 
significant reduction in serum total and ionized Ca and Mg  with 
out elevation in parathyroid hormone (53).         
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 CONCLUSIONS  
• Growth and sexual maturation were studied in IDDM children 
and adolescents with mean age 11.5 + 4.0 years. 
• The majority of type1 DM children and adolescents were 
originally from Arabic tribes, and from Central and North part 
of Sudan. 
• Most of children and adolescents had unsatisfactory school 
attendance and performance. 
• The majority of type1 DM children and adolescents had 
family history of diabetes mellitus. 
• The daily required dose applied by the majority per day 
0.5-1IU Insulin many of them did not comply with their doses 
of insulin mostly due to financial causes and ignorance.,                                
• Half of study groups had poor glyceamic control. 
• Growth retardation was found in 27.5% for HT/age. There 
was positive correlation between stunted growth and poor 
glycemic control (p= 0.001), inadequate nutrition, and DKA 
recurrence. 
• Moderate under weight was found in 24 (14.4%) and severe 
under weight was found in (8.7%). This was positively 
correlated with glyceamic control of diabetes (p= 0.002). 
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• Delayed puberty was found in 9 males and 10 females with 
positive correlation to duration of diabetes and poor 
glyceamic control. 
• Delayed skeletal maturation was found in (23.2%) the most 
affected group was the adolescents group.           
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RECOMMENDATIONS 
• This study recommends establishment of an intensive 
diabetic education program concentrating on self monitoring 
and insulin adjustment as well as diet. 
• It is high time to establish three or more insulin doses per 
day as basal bolus regimen has been shown that non of 
participant follow it to well motivated children and parents.       
• We recommended early strict glyceamic control to prevent 
the development of diabetes complication that affect growth, 
skeletal maturation and sexual maturation. 
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